{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T06:25:13Z","timestamp":1792650313928,"version":"4.5.0"},"reference-count":75,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,12,12]],"date-time":"2019-12-12T00:00:00Z","timestamp":1576108800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003132","name":"Agentschap voor Innovatie door Wetenschap en Technologie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003132","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007229","name":"Bijzonder Onderzoeksfonds","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007229","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2019.02920","type":"journal-article","created":{"date-parts":[[2019,12,12]],"date-time":"2019-12-12T14:38:28Z","timestamp":1576161508000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":27,"title":["Selective Engagement of Fc\u03b3RIV by a M2e-Specific Single Domain Antibody Construct Protects Against Influenza A Virus Infection"],"prefix":"10.3389","volume":"10","author":[{"given":"Dorien","family":"De Vlieger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katja","family":"Hoffmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inge","family":"Van Molle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wim","family":"Nerinckx","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lien","family":"Van Hoecke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marlies","family":"Ballegeer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Creytens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Remaut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hartmut","family":"Hengel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bert","family":"Schepens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Saelens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,12,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1093\/infdis\/jiy633","article-title":"Influenza vaccines: good, but we can do better","volume":"219","author":"Paules","year":"2019","journal-title":"J Infect Dis"},{"key":"B2","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.antiviral.2019.02.007","article-title":"Baloxavir marboxil susceptibility of influenza viruses from the Asia-Pacific, 2012\u20132018","volume":"164","author":"Koszalka","year":"2019","journal-title":"Antiviral Res."},{"key":"B3","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1097\/QCO.0000000000000498","article-title":"Neuraminidase inhibitor resistance in influenza: a clinical perspective","volume":"31","author":"Lee","year":"2018","journal-title":"Curr Opin Infect Dis."},{"key":"B4","doi-asserted-by":"publisher","first-page":"S68","DOI":"10.1093\/infdis\/jiz003","article-title":"The role of M2e in the development of universal influenza vaccines","volume":"219","author":"Saelens","year":"2019","journal-title":"J Infect Dis."},{"key":"B5","doi-asserted-by":"crossref","first-page":"5491","DOI":"10.1128\/JVI.65.10.5491-5498.1991","article-title":"Evolutionary analysis of the influenza A virus M gene with comparison of the M1 and M2 proteins","volume":"65","author":"Ito","year":"1991","journal-title":"J Virol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1038\/13484","article-title":"A universal influenza A vaccine based on the extracellular domain of the M2 protein","volume":"5","author":"Neirynck","year":"1999","journal-title":"Nat Med."},{"key":"B7","doi-asserted-by":"publisher","first-page":"2993","DOI":"10.1016\/j.vaccine.2004.02.021","article-title":"Preclinical study of influenza virus A M2 peptide conjugate vaccines in mice, ferrets, and rhesus monkeys","volume":"22","author":"Fan","year":"2004","journal-title":"Vaccine."},{"key":"B8","doi-asserted-by":"publisher","first-page":"5145","DOI":"10.1016\/j.vaccine.2011.05.041","article-title":"Safety and immunogenicity of a recombinant M2e-flagellin influenza vaccine (STF2.4xM2e) in healthy adults","volume":"29","author":"Turley","year":"2011","journal-title":"Vaccine."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1016\/0264-410X(95)92777-Y","article-title":"Protection of mice against influenza A virus challenge by vaccination with baculovirus-expressed M2 protein","volume":"13","author":"Slepushkin","year":"1995","journal-title":"Vaccine."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1093\/infdis\/jiu539","article-title":"Efficacy and safety of treatment with an anti-m2e monoclonal antibody in experimental human influenza","volume":"211","author":"Ramos","year":"2015","journal-title":"J Infect Dis"},{"key":"B11","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.antiviral.2017.02.016","article-title":"Bispecific T cell engaging antibody constructs targeting a universally conserved part of the viral M2 ectodomain cure and prevent influenza A virus infection","volume":"141","author":"Pendzialek","year":"2017","journal-title":"Antiviral Res."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.4049\/jimmunol.0902147","article-title":"Universal vaccine based on ectodomain of matrix protein 2 of influenza A: Fc receptors and alveolar macrophages mediate protection","volume":"186","author":"El Bakkouri","year":"2011","journal-title":"J Immunol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/JVI.02500-16","article-title":"Hierarchical and redundant roles of activating Fc\u03b3Rs in protection against influenza disease by M2e-specific IgG1 and IgG2a antibodies","volume":"91","author":"Van den Hoecke","year":"2017","journal-title":"J Virol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.antiviral.2014.08.016","article-title":"Evaluation of a fully human monoclonal antibody against multiple influenza A viral strains in mice and a pandemic H1N1 strain in nonhuman primates","volume":"111","author":"Song","year":"2014","journal-title":"Antiviral Res."},{"key":"B15","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/nri3582","article-title":"The function of Fc\u03b3 receptors in dendritic cells and macrophages","volume":"14","author":"Guilliams","year":"2014","journal-title":"Nat Rev Immunol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"5640","DOI":"10.1182\/blood-2012-01-380121","article-title":"Properties of mouse and human IgG receptors and their contribution to disease models","volume":"119","author":"Bruhns","year":"2012","journal-title":"Blood"},{"key":"B17","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1038\/341752a0","article-title":"A macrophage Fc gamma receptor and the mast cell receptor for IgE share an identical subunit","volume":"341","author":"Ra","year":"1989","journal-title":"Nature."},{"key":"B18","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/1074-7613(95)90134-5","article-title":"The same tyrosine-based inhibition motif, in the intracytoplasmic domain of Fc gamma RIIB, regulates negatively BCR-, TCR-, and FcR-dependent cell activation","volume":"3","author":"Da\u00ebron","year":"1995","journal-title":"Immunity"},{"key":"B19","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/0167-5699(95)80105-7","article-title":"New nomenclature for the Reth motif (or ARH1\/TAM\/ARAM\/YXXL)","volume":"16","author":"Cambier","year":"1995","journal-title":"Immunol Today."},{"key":"B20","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.immuni.2005.05.010","article-title":"FcgammaRIV: a novel FcR with distinct IgG subclass specificity","volume":"23","author":"Nimmerjahn","year":"2005","journal-title":"Immunity."},{"key":"B21","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/363446a0","article-title":"Naturally occurring antibodies devoid of light chains","volume":"363","author":"Hamers-Casterman","year":"1993","journal-title":"Nature."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.3389\/fimmu.2017.01802","article-title":"Single-domain antibodies as therapeutics against human viral diseases","volume":"8","author":"Wu","year":"2017","journal-title":"Front Immunol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/antib8010001","article-title":"Single-domain antibodies and their formatting to combat viral infections","volume":"8","author":"De Vlieger","year":"2019","journal-title":"Antibodies."},{"key":"B24","unstructured":"A Multicentre Study in Otherwise Healthy Infants and Toddlers Hospitalised For and Diagnosed With RSV Lower Respiratory Tract Infection to Evaluate the Safety, Tolerability, and Clinical Activity of ALX-0171 - Full Text View - ClinicalTrials.gov"},{"key":"B25","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/S0167-4838(99)00030-8","article-title":"Comparison of physical chemical properties of llama VHH antibody fragments and mouse monoclonal antibodies","volume":"1431","author":"van der Linden","year":"1999","journal-title":"Biochim Biophys Acta."},{"key":"B26","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1110\/ps.34602","article-title":"Single-domain antibody fragments with high conformational stability","volume":"11","author":"Dumoulin","year":"2002","journal-title":"Protein Sci."},{"key":"B27","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.pharmthera.2016.06.012","article-title":"Nanobodies\u00ae as inhaled biotherapeutics for lung diseases","volume":"169","author":"Van Heeke","year":"2017","journal-title":"Pharmacol Ther."},{"key":"B28","doi-asserted-by":"publisher","first-page":"11382","DOI":"10.1074\/jbc.M800650200","article-title":"An influenza A vaccine based on tetrameric ectodomain of matrix protein 2","volume":"283","author":"De Filette","year":"2008","journal-title":"J Biol Chem."},{"key":"B29","doi-asserted-by":"crossref","first-page":"5300","DOI":"10.4049\/jimmunol.160.11.5300","article-title":"Macrophages induce cellular immunity by activating Th1 cell responses and suppressing Th2 cell responses","volume":"160","author":"Desmedt","year":"1998","journal-title":"J Immunol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.jim.2012.09.006","article-title":"A novel assay for detecting virus-specific antibodies triggering activation of Fc\u03b3 receptors","volume":"387","author":"Corrales-Aguilar","year":"2013","journal-title":"J Immunol Methods."},{"key":"B31","doi-asserted-by":"publisher","first-page":"e1004131","DOI":"10.1371\/journal.ppat.1004131","article-title":"Human cytomegalovirus Fc\u03b3 binding proteins gp34 and gp68 antagonize Fc\u03b3 receptors I, II and III","volume":"10","author":"Corrales-Aguilar","year":"2014","journal-title":"PLoS Pathog."},{"key":"B32","doi-asserted-by":"publisher","first-page":"5696","DOI":"10.4049\/jimmunol.0903722","article-title":"A novel promiscuous class of camelid single-domain antibody contributes to the antigen-binding repertoire","volume":"184","author":"Deschacht","year":"2010","journal-title":"J Immunol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/1472-6750-9-70","article-title":"Efficient production of human bivalent and trivalent anti-MUC1 Fab-scFv antibodies in Pichia pastoris","volume":"9","author":"Schoonooghe","year":"2009","journal-title":"BMC Biotechnol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"44","DOI":"10.2144\/05381BM04","article-title":"Condensed protocol for competent cell preparation and transformation of the methylotrophic yeast Pichia pastoris","volume":"38","author":"Lin-Cereghino","year":"2005","journal-title":"BioTechniques."},{"key":"B35","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1107\/S0021889807021206","article-title":"Phaser crystallographic software","volume":"40","author":"McCoy","year":"2007","journal-title":"J Appl Crystallogr."},{"key":"B36","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1107\/S0907444909042589","article-title":"Molecular replacement with MOLREP","volume":"66","author":"Vagin","year":"2010","journal-title":"Acta Crystallogr D Biol Crystallogr."},{"key":"B37","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1107\/S0907444909052925","article-title":"PHENIX: a comprehensive Python-based system for macromolecular structure solution","volume":"66","author":"Adams","year":"2010","journal-title":"Acta Crystallogr D Biol Crystallogr."},{"key":"B38","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1107\/S0907444904019158","article-title":"Coot: model-building tools for molecular graphics","volume":"60","author":"Emsley","year":"2004","journal-title":"Acta Crystallogr D Biol Crystallogr."},{"key":"B39","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1107\/S0907444912001308","article-title":"Towards automated crystallographic structure refinement with phenix.refine","volume":"68","author":"Afonine","year":"2012","journal-title":"Acta Crystallogr D Biol Crystallogr."},{"key":"B40","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1107\/S0907444996012255","article-title":"Refinement of macromolecular structures by the maximum-likelihood method","volume":"53","author":"Murshudov","year":"1997","journal-title":"Acta Crystallogr D Biol Crystallogr."},{"key":"B41","doi-asserted-by":"publisher","first-page":"2714","DOI":"10.1002\/elps.1150181505","article-title":"SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling","volume":"18","author":"Guex","year":"1997","journal-title":"Electrophoresis."},{"key":"B42","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/1758-2946-4-17","article-title":"Avogadro: an advanced semantic chemical editor, visualization, and analysis platform","volume":"4","author":"Hanwell","year":"2012","journal-title":"J Cheminform."},{"key":"B43","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility","volume":"30","author":"Morris","year":"2009","journal-title":"J Comput Chem."},{"key":"B44","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J Comput Chem."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1021\/ci300604z","article-title":"Lessons learned in empirical scoring with smina from the CSAR 2011 benchmarking exercise","volume":"53","author":"Koes","year":"2013","journal-title":"J Chem Inf Model."},{"key":"B46","unstructured":"PyMOL | pymol.org"},{"key":"B47","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1104\/pp.113.217661","article-title":"GoldenBraid 2.0: a comprehensive DNA assembly framework for plant synthetic biology","volume":"162","author":"Sarrion-Perdigones","year":"2013","journal-title":"Plant Physiol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/protein\/gzm064","article-title":"Isolation and characterization of anti-FcgammaRIII (CD16) llama single-domain antibodies that activate natural killer cells","volume":"21","author":"Behar","year":"2008","journal-title":"Protein Eng Des Sel."},{"key":"B49","doi-asserted-by":"publisher","first-page":"19396","DOI":"10.1073\/pnas.1014515107","article-title":"Fc\u03b3RIV deletion reveals its central role for IgG2a and IgG2b activity in vivo","volume":"107","author":"Nimmerjahn","year":"2010","journal-title":"Proc Natl Acad Sci USA."},{"key":"B50","doi-asserted-by":"publisher","first-page":"3700","DOI":"10.1128\/JVI.02576-14","article-title":"Structure of the extracellular domain of matrix protein 2 of influenza A virus in complex with a protective monoclonal antibody","volume":"89","author":"Cho","year":"2015","journal-title":"J Virol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"7934","DOI":"10.1038\/s41598-018-26338-z","article-title":"The structural basis of nanobody unfolding reversibility and thermoresistance","volume":"8","author":"Kunz","year":"2018","journal-title":"Sci Rep."},{"key":"B52","doi-asserted-by":"publisher","first-page":"14158","DOI":"10.1038\/ncomms14158","article-title":"Potent single-domain antibodies that arrest respiratory syncytial virus fusion protein in its prefusion state","volume":"8","author":"Rossey","year":"2017","journal-title":"Nat Commun."},{"key":"B53","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1110\/ps.0201402","article-title":"3D domain swapping: as domains continue to swap","volume":"11","author":"Liu","year":"2002","journal-title":"Protein Sci."},{"key":"B54","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.1128\/JVI.62.8.2762-2772.1988","article-title":"Influenza A virus M2 protein: monoclonal antibody restriction of virus growth and detection of M2 in virions","volume":"62","author":"Zebedee","year":"1988","journal-title":"J Virol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.antiviral.2018.08.017","article-title":"Passively transferred M2e-specific monoclonal antibody reduces influenza A virus transmission in mice","volume":"158","author":"Kolpe","year":"2018","journal-title":"Antiviral Res."},{"key":"B56","doi-asserted-by":"publisher","first-page":"4450","DOI":"10.1038\/s41598-019-41023-5","article-title":"Super-resolution microscopy reveals significant impact of M2e-specific monoclonal antibodies on influenza A virus filament formation at the host cell surface","volume":"9","author":"Kolpe","year":"2019","journal-title":"Sci Rep."},{"key":"B57","doi-asserted-by":"publisher","first-page":"e28309","DOI":"10.1371\/journal.pone.0028309","article-title":"Potent neutralization of influenza A virus by a single-domain antibody blocking M2 ion channel protein","volume":"6","author":"Wei","year":"2011","journal-title":"PLoS ONE."},{"key":"B58","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1128\/JVI.02105-15","article-title":"Crystal structure of the conserved amino terminus of the extracellular domain of matrix protein 2 of influenza A virus gripped by an antibody","volume":"90","author":"Cho","year":"2015","journal-title":"J Virol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"6800","DOI":"10.1021\/acs.analchem.7b01221","article-title":"Comparison of three antihapten VHH selection strategies for the development of highly sensitive immunoassays for microcystins","volume":"89","author":"P\u00edrez-Schirmer","year":"2017","journal-title":"Anal Chem."},{"key":"B60","doi-asserted-by":"publisher","first-page":"4586","DOI":"10.1073\/pnas.0505379103","article-title":"Molecular basis for the preferential cleft recognition by dromedary heavy-chain antibodies","volume":"103","author":"De Genst","year":"2006","journal-title":"Proc Natl Acad Sci USA."},{"key":"B61","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.jmb.2010.07.001","article-title":"Structure and properties of a complex of \u03b1-synuclein and a single-domain camelid antibody","volume":"402","author":"De Genst","year":"2010","journal-title":"J Mol Biol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"19211","DOI":"10.1038\/srep19211","article-title":"Peptides in headlock \u2013 a novel high-affinity and versatile peptide-binding nanobody for proteomics and microscopy","volume":"6","author":"Braun","year":"2016","journal-title":"Sci Rep."},{"key":"B63","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.1016\/j.jmb.2018.04.021","article-title":"Artificial anti-tumor opsonizing proteins with fibronectin scaffolds engineered for specificity to each of the murine Fc\u03b3R types","volume":"430","author":"Chen","year":"2018","journal-title":"J Mol Biol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"6591","DOI":"10.1074\/jbc.M009483200","article-title":"High resolution mapping of the binding site on human IgG1 for Fc gamma RI, Fc gamma RII, Fc gamma RIII, and FcRn and design of IgG1 variants with improved binding to the Fc gamma R","volume":"276","author":"Shields","year":"2001","journal-title":"J Biol Chem."},{"key":"B65","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s10616-007-9103-2","article-title":"Non-fucosylated therapeutic antibodies: the next generation of therapeutic antibodies","volume":"55","author":"Mori","year":"2007","journal-title":"Cytotechnology."},{"key":"B66","doi-asserted-by":"publisher","first-page":"12650","DOI":"10.1074\/jbc.M700820200","article-title":"Improved pharmacokinetics of recombinant bispecific antibody molecules by fusion to human serum albumin","volume":"282","author":"M\u00fcller","year":"2007","journal-title":"J Biol Chem."},{"key":"B67","doi-asserted-by":"publisher","first-page":"5992","DOI":"10.1073\/pnas.1402458111","article-title":"Glycan variants of a respiratory syncytial virus antibody with enhanced effector function and in vivo efficacy","volume":"111","author":"Hiatt","year":"2014","journal-title":"Proc Natl Acad Sci USA."},{"key":"B68","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/JVI.00937-17","article-title":"Potent in vivo NK cell-mediated elimination of HIV-1-infected cells mobilized by a gp120-bispecific and hexavalent broadly neutralizing fusion protein","volume":"91","author":"Bardhi","year":"2017","journal-title":"J Virol."},{"key":"B69","doi-asserted-by":"publisher","first-page":"20690","DOI":"10.1073\/pnas.1108360108","article-title":"Enhanced potency of a fucose-free monoclonal antibody being developed as an Ebola virus immunoprotectant","volume":"108","author":"Zeitlin","year":"2011","journal-title":"Proc Natl Acad Sci USA."},{"key":"B70","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1158\/1535-7163.MCT-12-1012","article-title":"Single-domain antibody-based and linker-free bispecific antibodies targeting Fc\u03b3RIII induce potent antitumor activity without recruiting regulatory T cells","volume":"12","author":"Rozan","year":"2013","journal-title":"Mol Cancer Ther."},{"key":"B71","doi-asserted-by":"publisher","first-page":"5304","DOI":"10.18632\/oncotarget.2093","article-title":"A Fc\u03b3RIII-engaging bispecific antibody expands the range of HER2-expressing breast tumors eligible to antibody therapy","volume":"5","author":"Turini","year":"2014","journal-title":"Oncotarget."},{"key":"B72","doi-asserted-by":"publisher","first-page":"9130","DOI":"10.1038\/s41598-017-07966-3","article-title":"One-domain CD4 fused to human anti-CD16 antibody domain mediates effective killing of HIV-1-infected cells","volume":"7","author":"Li","year":"2017","journal-title":"Sci Rep."},{"key":"B73","doi-asserted-by":"publisher","first-page":"2674","DOI":"10.1158\/1535-7163.MCT-12-0692","article-title":"Bispecific and trispecific killer cell engagers directly activate human NK cells through CD16 signaling and induce cytotoxicity and cytokine production","volume":"11","author":"Gleason","year":"2012","journal-title":"Mol Cancer Ther."},{"key":"B74","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/nm.3443","article-title":"Broadly neutralizing hemagglutinin stalk-specific antibodies require Fc\u03b3R interactions for protection against influenza virus in vivo","volume":"20","author":"DiLillo","year":"2014","journal-title":"Nat Med."},{"key":"B75","doi-asserted-by":"publisher","first-page":"36","DOI":"10.3390\/vaccines6030036","article-title":"The role of Fc gamma receptors in broad protection against influenza viruses","volume":"6","author":"Thulin","year":"2018","journal-title":"Vaccines (Basel)."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.02920\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,23]],"date-time":"2023-09-23T22:44:58Z","timestamp":1695509098000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.02920\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,12]]},"references-count":75,"alternative-id":["10.3389\/fimmu.2019.02920"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2019.02920","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,12]]},"article-number":"2920"}}